DTIL

#3503
Precision BioSciences, Inc. Common Stock
4.20
+7.42%
版块:
基础:
利润货币:
日范围
4.20
4.20
年范围
3.53
8.82
日变化
+7.42%
每月变动
+2.94%
6个月变化
-16.67%
年变化
-22.22%
前一天收盘价
3.91
Open
4.20
Bid
Ask
Low
4.20
High
4.20
交易量
5
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Precision BioSciences Inc

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

新闻